CD44 protein expression levels in breast cancer tissues of 15 patients carrying the CC genotype were significantly lower than that in 12 patients carrying the CT or 4 patients carrying TT genotype (Kruskal Wallis Test: P = 0.003). This evidence concerns the gene CD44 and breast carcinoma.